en Gastroentrology Gastroentrology Original Article Original Article <span style="font-size:14px;"><span style="font-family:Times New Roman;"><span style="line-height:14pt"><b><i><span style="color:blue">Background</span></i></b><i><span style="color:blue">:</span></i> According to the significance of extraintestinal symptoms in inflammatory bowel disease (IBD) patients and their connection with obesity, we aimed to investigate the prevalence of fatty liver in IBD patients of Sayyad Shirazi Hospital in Gorgan, Iran, in relation to obesity, anthropometric indicators and body image in these patients.</span><br> <span style="line-height:14pt"><b><i><span style="color:blue">Methods:</span></i></b> Forty patients with IBD were recruited from all registered patients at the Golestan Research Center of Gastroenterology and Hepatology, following the specified inclusion and exclusion criteria. After obtaining written informed consent and filling in the questionnaire, the demographic and anthropometric indicators, and variables related to the disease were measured. The liver sonography was performed on all patients and graded by an expert radiologist. Data were analyzed using SPSS Version 16.0 statistical software at the significance level of 0.05.<span style="font-size:10.0pt"></span></span><br> <span style="line-height:14pt"><b><i><span style="color:blue">Results:</span></i></b> We showed no significant difference between the distribution of demographic and anthropometric indicators in different groups of IBD patients. However, we demonstrated that the inappropriate values of HDL (0.004) and high values of LDL (0.015) were associated with fatty liver in IBD patients. Our findings also showed that NAFLD was significantly associated with overweight and obesity among IBD patients (P = 0.003).<span style="font-size:10.0pt"></span></span><br> <span style="line-height:14pt"><b><i><span style="color:blue">Conclusion</span></i></b><i><span style="color:blue">:</span></i> Our findings showed the epidemiological burden of NAFLD in IBD patients. Since fatty liver was associated with obesity, it is recommended that IBD patients be screened for risk factors associated with NAFLD to prevent liver disease.<span style="font-size:10.0pt"></span></span></span></span><br> &nbsp; Inflammatory bowel disease (IBD), Ulcerative colitis (UC), Crohn's disease (CD), Obesity, Non-alcoholic fatty liver disease (NAFLD). 299 306 http://caspjim.com/browse.php?a_code=A-10-3115-1&slc_lang=en&sid=1 Sima Besharat s_besharat_gp@yahoo.com 100319475328460047752 100319475328460047752 No Infectious Diseases Research Center, Golestan University of Medical Sciences, Gorgan, Iran Farideh Sakhavi dr.f.sakhavi@gmail.com 100319475328460047753 100319475328460047753 No Golestan Research Center of Gastroentrology and Hepatology, Golestan University of Medical Sciences, Golestan, Gorgan, Iran Parsa Sookhtehsaraei drparsa75@gmail.com 100319475328460047754 100319475328460047754 No Golestan Research Center of Gastroentrology and Hepatology, Golestan University of Medical Sciences, Golestan, Gorgan, Iran Mehrdad Teimoorian mehrdadtm@gmail.com 100319475328460047755 100319475328460047755 No Golestan Research Center of Gastroentrology and Hepatology, Golestan University of Medical Sciences, Golestan, Gorgan, Iran Somayeh Livani dr_slivani@yahoo.com 100319475328460047756 100319475328460047756 No Clinical Research Development Unit (CRDU), Sayad Shirazi Hospital, Golestan University of Medical Sciences, Gorgan, Iran Alireza Norouzi Norouzi54@gmail.com 100319475328460047757 100319475328460047757 No Golestan Research Center of Gastroentrology and Hepatology, Golestan University of Medical Sciences, Golestan, Gorgan, Iran Taghi Amiriani Taghi.amiriani@gmail.com 100319475328460047758 100319475328460047758 Yes Golestan Research Center of Gastroentrology and Hepatology, Golestan University of Medical Sciences, Golestan, Gorgan, Iran